Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. - Wikidata - awgldk - TriplyDB

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

http://www.wikidata.org/entity/Q42982505

about

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4 Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam.Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada Hepatitis C virus in healthy blood donors in Sri Lanka The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis Molecular and contextual markers of hepatitis C virus and drug abuse.Cross sectional study of factors associated to self-reported blood-borne infections among drug users.Molecular methods of hepatitis C genotyping.Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages Improving outcome in patients with hepatitis C virus genotype 4.Current approaches to HCV infection in current and former injection drug users.Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran.Large scale screening of human sera for HCV RNA and GBV-C RNA.The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands.Coinfection with HIV and hepatitis C virus among injection drug users in southern China.Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves.

P2860

Q27014761-BAD22F9F-191E-40E9-9C1E-6E4BBC7F9C81 Q27486393-F9A33500-BF00-45A6-B930-511A9ABD903A Q27489900-5D82ABE7-9941-41CE-89DD-56BA7E884A6F Q27490460-563F71A3-368A-4729-B71C-811CE800EF04 Q27490866-EE19C6C2-AAAB-4332-80E3-3D9441F9AE81 Q30226978-15863329-C97C-4BC6-9240-02FE539518A7 Q30369227-F341CF63-41D1-4932-B420-055C0FE2DDE5 Q30429470-61B15DE3-665E-41D9-AF2A-2EA408E1B069 Q31149778-F49F6EDB-2A62-4396-B177-6677D4DCE342 Q33978978-7543D623-DFC1-41DF-863A-CF0B01054070 Q34063019-8DBF4A8C-4FB3-458F-87FD-4B4877DC56A5 Q34172845-CA9C6173-AFA7-40B0-A815-F2FA759E6033 Q34264303-EF197009-4351-4B1C-BD92-908CEBE6BC55 Q34415820-68AE1A06-F470-47B5-A16D-7A664426E8AE Q34862674-0568E1B8-3DCC-467C-8C13-016952A1458F Q34996891-479E79BE-C799-4B38-BB52-CE5CFA0013B8 Q35660841-2B8F7136-75F4-4586-AC66-25419EE0FA5B Q35841089-4D2416EB-999C-401F-AEA5-0B856F2BBE0D Q36192689-D530526F-1233-49A9-ABE9-6DCBC50666F0 Q36702487-833F66E7-F9E4-4D5C-9711-9A5F81126C90 Q36812856-819B3A10-3648-40ED-AECE-257822EECC8F Q36880945-A46FDD0B-8EBF-4818-AA4F-7B27C1F47849 Q36953707-C53C5267-D2FE-4B53-9B4C-DE1AC0F267E6 Q37235530-223EFA8C-9768-4776-8E49-5BEAC9BCCC5F Q37470458-5AAB0D1E-934C-48AF-84F3-1A3D01FF707A Q37626109-DBFEA38C-C22F-4999-A744-AA32BF257041 Q37712968-78974348-6E37-41B5-918C-91EC7254E309 Q37975114-C6AE2E23-DEAD-4B9A-914F-FCE92F4EF570 Q38381584-651E106E-2608-4FB1-BB15-8B98D4C9E1BE Q38613271-4A3C6848-1D9E-4394-8313-F15BC0C36E7E Q38929061-9174161D-321B-4785-9EFC-D70AE539535F Q38935930-2CCFF761-FD71-4C8D-BE40-6C4C5E65C0EB Q38962986-80D44B40-9712-4919-8B5A-2B53183DB1AF Q39411402-9965061D-F8DC-4646-B628-15851ABB3933 Q39634561-9D5A17FD-4BF4-46D3-B48C-E817A72E610A Q40375524-BCDC1A55-8281-492C-B19A-FCA612DC78ED Q40857029-306014AE-9EDF-49E4-A93E-C9405C49B183 Q41047662-45023798-F808-4146-BCDE-07F90FA71AE4 Q41920886-35EDE56C-75A0-45B5-BEC4-542996BFB99A Q42254820-EEFA4381-BC0C-4E4F-892F-24C28CBA55EF

P2860

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

http://www.wikidata.org/entity/Q42982505

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@en

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@nl

type

label

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@en

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@nl

prefLabel

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@en

Spread of hepatitis C virus am ...... HIV: a phylogenetic analysis.

@nl

P1433

Q42982505-F8C50942-F067-4B97-811B-888F95667AF3

P1476

Q42982505-B24A7AE6-D6A2-442C-B28F-DC8BC2F47FE9

P2093

Q42982505-0D57CC61-9529-4F10-94B9-37C20215B424

Q42982505-2C63550F-AF54-4923-B8DD-88D8746CE08C

Q42982505-3B6D007A-DB84-456E-A382-66D5A496E250

Q42982505-4EE3F79C-7C98-4303-B413-9321C54D3EB6

Q42982505-5159A0F7-9F26-4EF2-AEEC-770407BAE840

Q42982505-530AE8DD-151E-4C07-8FAB-282A9C189473

Q42982505-569FE559-1B9C-4528-87F0-29A4E8CA5185

Q42982505-8AC4C9CF-036C-437A-884E-0AB0E562E261

Q42982505-954AAE7F-E0CF-495E-A56E-6EC49C556E2E

Q42982505-B04E1A84-F643-4A35-9636-56103AA3F10A

P304

Q42982505-42A00B19-CF02-450D-A5F9-813AF1061635

P31

Q42982505-7CB85065-B6E3-4471-A16B-488F05ACE20C

P356

Q42982505-32A15534-5FE1-4741-AEEF-42B540FC54DD

P407

Q42982505-5E351F37-35ED-42D2-986C-C06FEC96DB6B

P433

Q42982505-A6492F10-3A80-45C8-9C0E-99586D7CE671

P478

Q42982505-33FB1232-AE04-4FA4-A1E2-8EADFEC58E1B

P50

Q42982505-0823ECDE-169B-401D-BB24-F6F0C037666E

Q42982505-0986D053-738F-4C99-AF20-6A7EACFC2F2A

Q42982505-4A00D251-1C16-4387-8775-E4C1A96BF644

Q42982505-DCA12900-7E54-4671-84A0-320A0D8997AB

Q42982505-E14C3716-7AD0-4303-9322-39FDEFB0F7E5

P577

Q42982505-AC2B18D6-8FED-44D1-BCDD-5B810C0DCF7A

P5875

Q42982505-8F083157-8A0D-4489-B5C2-847BCA2D4672

P698

Q42982505-1904C2D2-A4EA-4EF6-90EC-E46783BB375E

P921

Q42982505-F91846FA-3570-4B3E-AD50-616B870F5EBD

P356

P1433

The Journal of Infectious Diseases

P1476

Spread of hepatitis C virus am ...... h HIV: a phylogenetic analysis

@en

P2093

Alexandra Cochrane

http://www.w3.org/2001/XMLSchema#string

Barbara Broers

http://www.w3.org/2001/XMLSchema#string

European and Italian Seroconverter Studies

http://www.w3.org/2001/XMLSchema#string

Faroudy Boufassa

http://www.w3.org/2001/XMLSchema#string

Giovanni Rezza

http://www.w3.org/2001/XMLSchema#string

Inge Verhaest

http://www.w3.org/2001/XMLSchema#string

J Roy Robertson

http://www.w3.org/2001/XMLSchema#string

Raymond P Brettle

http://www.w3.org/2001/XMLSchema#string

Robert Zangerle

http://www.w3.org/2001/XMLSchema#string

Roel A Coutinho

http://www.w3.org/2001/XMLSchema#string

P304

292-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/380821

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

Ildefonso Hernández-Aguado

Liselotte van Asten

P577

2004-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8919986

http://www.w3.org/2001/XMLSchema#string

P698

14722895

http://www.w3.org/2001/XMLSchema#string

P921